Senseonics Holdings宣布,其Eversense 365与iLet系统的整合开发工作,预计将于2026年第四季度圆满收官。这一时间表的确认,标志着公司在推进连续血糖监测技术与胰岛素输送系统深度融合的进程中,迈出了坚实而关键的一步。
Senseonics Holdings宣布,其Eversense 365与iLet系统的整合开发工作,预计将于2026年第四季度圆满收官。这一时间表的确认,标志着公司在推进连续血糖监测技术与胰岛素输送系统深度融合的进程中,迈出了坚实而关键的一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.